| HDA方案治疗急性非淋巴细胞白血病临床研究 |
| |
| 引用本文： | 赵秀兰,殷晓华,陈方,李丹红,张晓敏. HDA方案治疗急性非淋巴细胞白血病临床研究[J]. 白血病．淋巴瘤, 1994, 0(3) |
| |
| 作者姓名： | 赵秀兰 殷晓华 陈方 李丹红 张晓敏 |
| |
| 作者单位： | 牡丹江医学院血液病研究所 |
| |
| 摘 要： | １９８５年～１９９３年收治急性非淋巴细胞白血病（ＡＮＬＬ）２１８例，用ＨＤＡ方案治疗７２例，ＣＲ率为７６．３８％、ＨＡ方案治疗７８例，ＣＲ率４４．８７％、ＤＡ方案治疗６８例，ＣＲ率４８．８５％，ＨＤＡ组与ＨＡ、ＤＡ组疗效差异显著（Ｐ＜０．００５），ＣＲ后必须坚持长期多疗程的强化治疗才能延长生存期、提高治愈率。
|
| 关 键 词： | 急性非淋巴细胞白血病（ANLL），完全缓解（CR） |
CLINICAL STUDY ON THE TREATMENT OF ACUTE NONLYMPHOBLASTIC LEUKEMIA WITH HDA REGIMEN |
| |
| zhao XiulaN,et al Institute of Hematology,Mudan jiang Medical College. CLINICAL STUDY ON THE TREATMENT OF ACUTE NONLYMPHOBLASTIC LEUKEMIA WITH HDA REGIMEN[J]. Journal of Leukemia & Lymphoma, 1994, 0(3) |
| |
| Authors: | zhao XiulaN et al Institute of Hematology Mudan jiang Medical College |
| |
| Abstract: | 18 cases of acute on lymphoblastic leukemia(ANLL)were treated with HDA,HA and DA regimens from 1985 to 1993. The CR rates in HDA group(72cases),HA group(78cases)and DAgroup(68cases)were 76.38%,44.87%and 48.85%respectively. The CR rate in HDA group wassignificantly higher than that in HA and DA groups(P<0.005).After CR,continuous,multiple andintensive treatment were needed to prolong the life-spans of the patients and improve the CR rate. |
| |
| Keywords: | ANLL CR |
| 本文献已被 CNKI 等数据库收录！ |
|
